← Leaderboards
Jamie L Renbarger
Indiana Univ-Purdue Univ At Indianapolis
$11,642,876
Attributed
$13,307,942
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$20,735,416 · 14
By mechanism
U54$9,330,987 · 6
R01$5,498,782 · 2
P50$2,344,390 · 3
T32$1,903,388 · 1
RC1$986,304 · 1
K23$671,565 · 1
Top collaborators
- David Alastair Flockhart10 shared
- Sophie Paczesny5 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Kent A Robertson$1,570,412
- Lang Li$13,579,025
- Daniel R Meldrum$3,269,550
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodPharmaceutical PreparationsChildGenomicsInnovationIndianaPediatric PharmacologyUniversitiesBaseToxic EffectMalignant NeoplasmsResponseMalignant Childhood NeoplasmResearch PersonnelDoseAdultEvaluationLeadPathway InteractionsData SetAdverse EffectsIn VitroPharmacogeneticsArea
Grant awards (58)
Indiana University Center for Pediatric Pharmacology and Precision Medicine$676,502
P50 · FY2020 · HD · contact PI
Administrative Core$279,420
P50 · FY2020 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology$227,281
T32 · FY2020 · HD · contact PI
Project 1: Optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.$194,824
P50 · FY2020 · HD · contact PI
Indiana University Center for Pediatric Pharmacology and Precision Medicine$697,951
P50 · FY2019 · HD · contact PI
Administrative Core$279,420
P50 · FY2019 · HD · contact PI
Project 1: Optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.$216,273
P50 · FY2019 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology$204,103
T32 · FY2019 · HD · contact PI
Indiana University Center for Pediatric Pharmacology and Precision Medicine$709,014
U54 · FY2018 · HD · contact PI
Administrative Core$279,420
U54 · FY2018 · HD · contact PI
Project 1: Optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.$216,273
U54 · FY2018 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology$213,175
T32 · FY2018 · HD · contact PI
Indiana University Center for Pediatric Pharmacology and Precision Medicine$749,663
U54 · FY2017 · HD · contact PI
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease$491,398
R01 · FY2017 · HD
Administrative Core$276,660
U54 · FY2017 · HD · contact PI
Project 1: Optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.$259,745
U54 · FY2017 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology$154,509
T32 · FY2017 · HD · contact PI
Indiana University Center for Pediatric Pharmacology and Precision Medicine$823,069
U54 · FY2016 · HD · contact PI
Pharmacogenetic Determinants of Vincristine Toxicity and Response$614,577
R01 · FY2016 · HD · contact PI
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease$505,765
R01 · FY2016 · HD
Administrative Core$288,713
U54 · FY2016 · HD · contact PI
Project 1: Optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.$278,802
U54 · FY2016 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology$213,829
T32 · FY2016 · HD · contact PI
Indiana University Center for Pediatric Pharmacology$758,925
U54 · FY2015 · HD · contact PI
Pharmacogenetic Determinants of Vincristine Toxicity and Response$493,265
R01 · FY2015 · HD · contact PI
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease$458,943
R01 · FY2015 · HD
Administrative Core$217,725
U54 · FY2015 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical Pharmacology$184,020
T32 · FY2015 · HD · contact PI
Biomarkers of vincristine-induced peripheral neuropathy$123,136
U54 · FY2015 · HD · contact PI
Indiana University Center for Pediatric Pharmacology$737,674
U54 · FY2014 · HD · contact PI
Pharmacogenetic Determinants of Vincristine Toxicity and Response$485,538
R01 · FY2014 · HD · contact PI
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease$454,296
R01 · FY2014 · HD
Administrative Core$213,859
U54 · FY2014 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical Pharmacology$181,411
T32 · FY2014 · HD · contact PI
Biomarkers of vincristine-induced peripheral neuropathy$105,884
U54 · FY2014 · HD · contact PI
Indiana University Center for Pediatric Pharmacology$722,098
U54 · FY2013 · HD · contact PI
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease$529,239
R01 · FY2013 · HD
Pharmacogenetic Determinants of Vincristine Toxicity and Response$406,355
R01 · FY2013 · HD · contact PI
Administrative Core$206,760
U54 · FY2013 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical Pharmacology$198,754
T32 · FY2013 · HD · contact PI
Biomarkers of vincristine-induced peripheral neuropathy$110,084
U54 · FY2013 · HD · contact PI
Indiana University Center for Pediatric Pharmacology$765,284
U54 · FY2012 · HD · contact PI
Pharmacogenetic Determinants of Vincristine Toxicity and Response$621,364
R01 · FY2012 · HD · contact PI
Administrative Core$216,890
U54 · FY2012 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical Pharmacology$200,406
T32 · FY2012 · HD · contact PI
Biomarkers of vincristine-induced peripheral neuropathy$124,708
U54 · FY2012 · HD · contact PI
Indiana University Center for Pediatric Pharmacology$787,294
U54 · FY2011 · HD · contact PI
Pharmacogenetic Determinants of Vincristine Toxicity and Response$438,042
R01 · FY2011 · HD · contact PI
Administrative Core$222,524
U54 · FY2011 · HD · contact PI
Biomarkers of vincristine-induced peripheral neuropathy$136,783
U54 · FY2011 · HD · contact PI
Postdoctoral Research Training in Pediatric Clinical Pharmacology$125,900
T32 · FY2011 · HD · contact PI
Developing a prediction model for vincristine-induced peripheral neuropathy$493,455
RC1 · FY2010 · CA · contact PI
Developing a prediction model for vincristine-induced peripheral neuropathy$492,849
RC1 · FY2009 · CA · contact PI
Pharmacogenetic Determinants of Vinca Alkaloid Response$135,778
K23 · FY2009 · RR · contact PI
Pharmacogenetic Determinants of Vinca Alkaloid Response$134,210
K23 · FY2008 · RR · contact PI
Pharmacogenetic Determinants of Vinca Alkaloid Response$132,687
K23 · FY2007 · RR · contact PI
Pharmacogenetic Determinants of Vinca Alkaloid Response$132,567
K23 · FY2006 · RR · contact PI
Pharmacogenetic Determinants of Vinca Alkaloid Response$136,323
K23 · FY2005 · RR